aminolevulinic acid has been researched along with Adenocarcinoma in 96 studies
Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS.
5-aminolevulinic acid : The simplest delta-amino acid in which the hydrogens at the gamma position are replaced by an oxo group. It is metabolised to protoporphyrin IX, a photoactive compound which accumulates in the skin. Used (in the form of the hydrochloride salt)in combination with blue light illumination for the treatment of minimally to moderately thick actinic keratosis of the face or scalp.
Adenocarcinoma: A malignant epithelial tumor with a glandular organization.
| Excerpt | Relevance | Reference |
|---|---|---|
| " This research aimed to assess the cytogenetic potential of 5-aminolevulinic acid (5-ALA) activated with laser irradiation (5-ALA/PDT) to damage the intact DNA of adenocarcinoma breast cancer cell line (MCF-7) and hepatocellular carcinoma cell line (HepG2)." | 7.88 | Photodynamic therapy using 5-aminolevulinic acid triggered DNA damage of adenocarcinoma breast cancer and hepatocellular carcinoma cell lines. ( Abo-Elfadl, MT; Abo-Zeid, MAM; Mostafa, SM, 2018) |
| "5-aminolevulinic acid heptyl ester was investigated in human adenocarcinoma WiDr cells and in healthy skin of athymic nude mice in comparison with 5-aminolevulinic acid (ALA)." | 7.75 | A comparison of 5-aminolaevulinic acid- and its heptyl ester: dark cytotoxicity and protoporphyrin IX synthesis in human adenocarcinoma WiDr cells and in athymic nude mice healthy skin. ( Iani, V; Juzeniene, A; Ma, LW; Moan, J; Pudroma, X, 2009) |
| "BALB/c nude mice bearing WiDr human colon adenocarcinoma were used to determine the effect of ultrasound on the production of 5-aminolevulinic acid (ALA)-induced protoporphyrin IX (PpIX) both in the tumors and in skin overlying the tumors." | 7.70 | Production of protoporphyrin IX induced by 5-aminolevulinic acid in transplanted human colon adenocarcinoma of nude mice can be increased by ultrasound. ( Iani, V; Ma, L; Moan, J; Peng, Q, 1998) |
| "5-aminolevulinic acid (5-ALA) is a constituent of mitochondrial electron carriers, heme and cytochrome c, which are crucial for aerobic energy metabolism and cell apoptosis." | 5.56 | Inhibitory Effect of Orally Administered 5-Aminolevulinic Acid on Prostate Carcinogenesis in the FVB-Transgenic Adenocarcinoma of a Mouse Prostate (FVB-TRAMP) Model. ( Anai, S; Fujimoto, K; Hori, S; Iemura, Y; Iida, K; Itami, Y; Miyake, M; Nakai, Y; Onishi, K; Onishi, S; Owari, T; Shimada, K; Tanaka, N; Tatsumi, Y, 2020) |
| "In the control group, prostate cancer was pathologically detected in 33 and 50 % of mice at 12 and 20 weeks, respectively, while 25% of 12-week old mice in the low-dose group were affected and none of the high-dose group mice developed prostate cancer." | 5.56 | Inhibitory Effect of Orally Administered 5-Aminolevulinic Acid on Prostate Carcinogenesis in the FVB-Transgenic Adenocarcinoma of a Mouse Prostate (FVB-TRAMP) Model. ( Anai, S; Fujimoto, K; Hori, S; Iemura, Y; Iida, K; Itami, Y; Miyake, M; Nakai, Y; Onishi, K; Onishi, S; Owari, T; Shimada, K; Tanaka, N; Tatsumi, Y, 2020) |
| "5-Aminolevulinic acid (ALA) is a natural heme precursor metabolized into protoporphyrin IX (PpIX)." | 5.40 | Synergistic apoptotic effect of Doxil ® and aminolevulinic acid-based photodynamic therapy on human breast adenocarcinoma cells. ( El-Daly, SM; Gamal-Eldeen, AM; Saleh, S; Zakaria, S, 2014) |
| "5-aminolevulinic acid heptyl ester was investigated in human adenocarcinoma WiDr cells and in healthy skin of athymic nude mice in comparison with 5-aminolevulinic acid (ALA)." | 5.35 | A comparison of 5-aminolaevulinic acid- and its heptyl ester: dark cytotoxicity and protoporphyrin IX synthesis in human adenocarcinoma WiDr cells and in athymic nude mice healthy skin. ( Iani, V; Juzeniene, A; Ma, LW; Moan, J; Pudroma, X, 2009) |
| "Most lesions of superficial bladder cancer may be easily missed during conventional white light cystoscopy." | 5.31 | Significance of fluorescence cystoscopy for diagnosis of superficial bladder cancer after intravesical instillation of delta aminolevulinic acid. ( Ehsan, A; Engelmann, U; Haupt, G; Sommer, F, 2001) |
| " This research aimed to assess the cytogenetic potential of 5-aminolevulinic acid (5-ALA) activated with laser irradiation (5-ALA/PDT) to damage the intact DNA of adenocarcinoma breast cancer cell line (MCF-7) and hepatocellular carcinoma cell line (HepG2)." | 3.88 | Photodynamic therapy using 5-aminolevulinic acid triggered DNA damage of adenocarcinoma breast cancer and hepatocellular carcinoma cell lines. ( Abo-Elfadl, MT; Abo-Zeid, MAM; Mostafa, SM, 2018) |
| " We recently showed that irradiating breast cancer COH-BR1 cells after treating with 5-aminolevulinic acid (ALA, a pro-sensitizer) resulted in rapid upregulation of inducible nitric oxide (NO) synthase (iNOS)." | 3.79 | Cytoprotective signaling associated with nitric oxide upregulation in tumor cells subjected to photodynamic therapy-like oxidative stress. ( Bhowmick, R; Girotti, AW, 2013) |
| "5-aminolevulinic acid heptyl ester was investigated in human adenocarcinoma WiDr cells and in healthy skin of athymic nude mice in comparison with 5-aminolevulinic acid (ALA)." | 3.75 | A comparison of 5-aminolaevulinic acid- and its heptyl ester: dark cytotoxicity and protoporphyrin IX synthesis in human adenocarcinoma WiDr cells and in athymic nude mice healthy skin. ( Iani, V; Juzeniene, A; Ma, LW; Moan, J; Pudroma, X, 2009) |
| "5-Aminolevulinic acid (ALA) or its derivative methyl 5-aminolevulinate (MAL) combined with folic acid was applied in nude mice bearing human colon adenocarcinoma." | 3.73 | The effect of folic acid on porphyrin synthesis in tumors and normal skin of mice treated with 5-aminolevulinic acid or methyl 5-aminolevulinate. ( Iani, V; Juzeniene, A; Ma, L; Moan, J; Steindal, AE, 2006) |
| " It is shown that sublethal PDT of human WiDr adenocarcinoma cells and D54Mg glioblastoma cells with 5-aminolevulinic acid (ALA), disulfonated tetraphenylporphyrine (TPPS(2a)), or MitoTracker Red (MTR) inhibits their trypsin-induced detachment from a plastic substratum." | 3.72 | Photodynamic inhibition of enzymatic detachment of human cancer cells from a substratum. ( Juzeniene, A; Ma, LW; Moan, J; Uzdensky, A, 2004) |
| "The photodynamic effect of a photoproduct of protoporphyrin IX (PpIX) induced by 5-aminolevulinic acid (ALA) was investigated in WiDr cells, a human adenocarcinoma cell line." | 3.71 | The photosensitizing effect of the photoproduct of protoporphyrin IX. ( Bagdonas, S; Ma, L; Moan, J, 2001) |
| "The transport mechanisms of 5-aminolevulinic acid methyl ester (5-ALA-ME) have been studied in a human adenocarcinoma cell line (WiDr) by means of 14[C]-labeled 5-ALA-ME." | 3.71 | 5-Aminolaevulinic acid methyl ester transport on amino acid carriers in a human colon adenocarcinoma cell line. ( Berg, K; Brown, SB; Gederaas, OA; Holroyd, A; Moan, J; Vernon, D, 2001) |
| "Human adenocarcinoma cells of the line WiDr and human leukemia T cells of the line Jurkat were incubated with 5-aminolevulinic acid and found to produce protoporphyrin IX (PpIX)." | 3.71 | Transfer of protoporphyrin IX between cells. ( Ma, LW; Moan, J; Stokke, T, 2002) |
| "Primary adenocarcinoma cells of the rectosigmoid colon (WiDr-cells) were treated with 5-aminolevulinic acid (5-ALA)." | 3.70 | A comparative study of normal and reverse phase high pressure liquid chromatography for analysis of porphyrins accumulated after 5-aminolaevulinic acid treatment of colon adenocarcinoma cells. ( Berg, K; Gederaas, OA; Romslo, I, 2000) |
| "BALB/c nude mice bearing WiDr human colon adenocarcinoma were used to determine the effect of ultrasound on the production of 5-aminolevulinic acid (ALA)-induced protoporphyrin IX (PpIX) both in the tumors and in skin overlying the tumors." | 3.70 | Production of protoporphyrin IX induced by 5-aminolevulinic acid in transplanted human colon adenocarcinoma of nude mice can be increased by ultrasound. ( Iani, V; Ma, L; Moan, J; Peng, Q, 1998) |
| "Human colon adenocarcinoma cells (WiDr) and Chinese hamster lung fibroblasts cells (V79) were incubated with different concentrations of 5-aminolevulinic acid (ALA), and the production of protoporphyrin IX (PpIX) was studied using several techniques." | 3.70 | Protoporphyrin IX accumulation in cells treated with 5-aminolevulinic acid: dependence on cell density, cell size and cell cycle. ( Bech, O; Berg, K; Gaullier, JM; Ma, LW; Moan, J; Steen, HB; Stokke, T, 1998) |
| "The response of human colon adenocarcinoma cells of the line WiDr to the combined treatment of ionizing radiation and photosensitization by 5-aminolevulinic acid-induced protoporphyrin IX was assessed by a colony-forming assay." | 3.69 | Combined treatment of ionizing radiation and photosensitization by 5-aminolevulinic acid-induced protoporphyrin IX. ( Berg, K; Luksiene, Z; Ma, L; Moan, J, 1995) |
| "We examined the effectiveness of systemic administration of delta-aminolevulinic acid (delta-ALA) to induce endogenous protoporphyrin as a regimen for use in photodynamic therapy (PDT) of transplanted R3230AC rat mammary adenocarcinomas in vivo." | 3.69 | Effectiveness of delta-aminolevulinic acid-induced protoporphyrin as a photosensitizer for photodynamic therapy in vivo. ( Foster, TH; Gibson, SL; Hilf, R; Hua, Z, 1995) |
| "Human tumor cells of the lines WiDr (adenocarcinoma of the rectosigmoid colon), NHIK 3025 (carcinoma of the cervix), and V79 Chinese hamster fibroblasts were treated with 5-aminolevulinic acid (ALA) and ALA esterified to C1-C3 and C6-C8 chained aliphatic alcohols (ALA-esters)." | 3.69 | Use of 5-aminolevulinic acid esters to improve photodynamic therapy on cells in culture. ( Anholt, H; Berg, K; Gaullier, JM; Ma, LW; Moan, J; Peng, Q; Selbo, PK, 1997) |
| "Chinese hamster cells (V79) and human adenocarcinoma cells (WiDr) were incubated with 5-aminolevulinic acid (ALA) at different pH values and the rate of production of protoporphyrin IX (PpIX) was measured." | 3.69 | The pH dependency of protoporphyrin IX formation in cells incubated with 5-aminolevulinic acid. ( Bech, O; Berg, K; Moan, J, 1997) |
| "Nineteen patients with localized prostate cancer were included in the study." | 2.72 | Photodynamic selectivity of 5-aminolevulinic acid to prostate cancer cells. ( Abdel-Gawad, O; El-Doray, AA; El-Mahdy, Ael-D; Hofstetter, A; Khoder, W; Sultan, SM, 2006) |
| "Reduction of tumor stenosis, increase in quality of life, and phototoxicity were considered as primary objectives." | 2.70 | Comparison of 5-aminolaevulinic acid and porphyrin photosensitization for photodynamic therapy of malignant bronchial stenosis: a clinical pilot study. ( Anegg, U; Fell, B; Maier, A; Matzi, V; Pinter, H; Rehak, P; Smolle-Jüttner, FM; Tomaselli, F; Woltsche, M, 2002) |
| "Improvement regarding dysphagia, stenosis diameter, and tumor length could be obtained in both treatment arms with a significant difference in favour of the Photosan-group, P = 0." | 2.70 | Does new photosensitizer improve photodynamic therapy in advanced esophageal carcinoma? ( Maier, A; Matzi, V; Pinter, H; Rehak, P; Smolle-Jüttner, FM; Tomaselli, F, 2001) |
| "Two patients had squamous cell carcinoma of the mid-esophagus and three had adenocarcinoma of the distal esophagus." | 2.69 | Photodynamic therapy of cancer of the esophagus using systemic aminolevulinic acid and a non laser light source: a phase I/II study. ( Haddad, R; Kashtan, H; Konikoff, F; Skornick, Y, 1999) |
| "For large areas of Bowen's disease, particularly in anatomically difficult areas and in elderly patients, PDT using ALA may constitute a single simple alternative outpatient treatment to existing therapies." | 2.67 | Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer. ( Ash, DV; Brown, SB; Cairnduff, F; Hudson, EJ; Stringer, MR, 1994) |
| "Barrett's esophagus is a precursor of adenocarcinoma of the esophagus." | 2.42 | 5-Aminolaevulinic acid-induced photodynamic therapy and photodetection in Barrett's esophagus. ( Ackroyd, R; Claydon, PE, 2004) |
| "Surveillance of Barrett's esophagus is routinely undertaken to detect early malignant transformation." | 2.42 | 5-Aminolaevulinic acid-induced photodynamic therapy and photodetection in Barrett's esophagus. ( Ackroyd, R; Claydon, PE, 2004) |
| "5-aminolevulinic acid (5-ALA) is a constituent of mitochondrial electron carriers, heme and cytochrome c, which are crucial for aerobic energy metabolism and cell apoptosis." | 1.56 | Inhibitory Effect of Orally Administered 5-Aminolevulinic Acid on Prostate Carcinogenesis in the FVB-Transgenic Adenocarcinoma of a Mouse Prostate (FVB-TRAMP) Model. ( Anai, S; Fujimoto, K; Hori, S; Iemura, Y; Iida, K; Itami, Y; Miyake, M; Nakai, Y; Onishi, K; Onishi, S; Owari, T; Shimada, K; Tanaka, N; Tatsumi, Y, 2020) |
| "In the control group, prostate cancer was pathologically detected in 33 and 50 % of mice at 12 and 20 weeks, respectively, while 25% of 12-week old mice in the low-dose group were affected and none of the high-dose group mice developed prostate cancer." | 1.56 | Inhibitory Effect of Orally Administered 5-Aminolevulinic Acid on Prostate Carcinogenesis in the FVB-Transgenic Adenocarcinoma of a Mouse Prostate (FVB-TRAMP) Model. ( Anai, S; Fujimoto, K; Hori, S; Iemura, Y; Iida, K; Itami, Y; Miyake, M; Nakai, Y; Onishi, K; Onishi, S; Owari, T; Shimada, K; Tanaka, N; Tatsumi, Y, 2020) |
| "5-aminolevulinic acid (5-ALA) has been utilized for cancer diagnosis as a fluorescence probe." | 1.56 | 5-ALA-assistant automated detection of lymph node metastasis in gastric cancer patients. ( Harada, Y; Koshiishi, N; Matsumoto, T; Matsuo, H; Murayama, Y; Okochi, K; Otsuji, E; Takamatsu, T; Tanaka, H, 2020) |
| "The expression of PPOX was higher in tubular adenocarcinoma (tub) than in signet-ring cell carcinoma (sig)." | 1.48 | Protoporphyrinogen oxidase is involved in the fluorescence intensity of 5-aminolevulinic acid-mediated laser-based photodynamic endoscopic diagnosis for early gastric cancer. ( Fujiwara, Y; Isomoto, H; Kanda, T; Kawaguchi, K; Koda, H; Kurumi, H; Matsushima, K; Nakao, K; Ogihara, K; Okada, F; Osaki, M; Saito, H; Yashima, K, 2018) |
| "5-Aminolevulinic acid (ALA) is a natural heme precursor metabolized into protoporphyrin IX (PpIX)." | 1.40 | Synergistic apoptotic effect of Doxil ® and aminolevulinic acid-based photodynamic therapy on human breast adenocarcinoma cells. ( El-Daly, SM; Gamal-Eldeen, AM; Saleh, S; Zakaria, S, 2014) |
| "We recently showed that irradiating breast cancer COH-BR1 cells after treating with 5-aminolevulinic acid (ALA, a pro-sensitizer) resulted in rapid upregulation of inducible nitric oxide (NO) synthase (iNOS)." | 1.39 | Cytoprotective signaling associated with nitric oxide upregulation in tumor cells subjected to photodynamic therapy-like oxidative stress. ( Bhowmick, R; Girotti, AW, 2013) |
| "Lymph node metastasis is one of the most critical prognostic factors in patients with colorectal cancer." | 1.38 | Fluorescence diagnosis of metastatic lymph nodes using 5-aminolevulinic acid (5-ALA) in a mouse model of colon cancer. ( Hasegawa, S; Kato, S; Kawada, K; Kawamura, J; Sakai, Y, 2012) |
| "An orthotopic colon cancer model was prepared by inoculating the cecal wall of nude mice with HCA7, a human colon adenocarcinoma cell line." | 1.38 | Fluorescence diagnosis of metastatic lymph nodes using 5-aminolevulinic acid (5-ALA) in a mouse model of colon cancer. ( Hasegawa, S; Kato, S; Kawada, K; Kawamura, J; Sakai, Y, 2012) |
| "Peritoneal carcinomatosis was induced by intraperitoneal 5×10(6)NuTu-19 cells injection in 60 female rats Fisher 344." | 1.36 | Continuous or fractionated photodynamic therapy? Comparison of three PDT schemes for ovarian peritoneal micrometastasis treatment in a rat model. ( Ascencio, M; Colin, P; Collinet, P; Estevez, JP; Farine, MO; Mordon, S, 2010) |
| "5-aminolevulinic acid heptyl ester was investigated in human adenocarcinoma WiDr cells and in healthy skin of athymic nude mice in comparison with 5-aminolevulinic acid (ALA)." | 1.35 | A comparison of 5-aminolaevulinic acid- and its heptyl ester: dark cytotoxicity and protoporphyrin IX synthesis in human adenocarcinoma WiDr cells and in athymic nude mice healthy skin. ( Iani, V; Juzeniene, A; Ma, LW; Moan, J; Pudroma, X, 2009) |
| "5-aminolevulinic acid (5-ALA) is a precursor in synthesis of endogenous porphyrins used to sensitize tumor tissues in photodynamic therapy (PDT)." | 1.32 | Enhancement of photodynamic therapy by use of aminolevulinic acid/glycolic acid drug mixture. ( Bronowicz, A; Oremek, G; Osiecka, BJ; Saleh, Y; Siewinski, M; Symonowicz, K; Ziolkowski, P, 2004) |
| "Hypericin is a very promising new photosensitizer for innovative photodynamic therapy of esophageal cancer." | 1.32 | Hypericin activated by an incoherent light source has photodynamic effects on esophageal cancer cells. ( Höpfner, M; Kashtan, H; Lenz, M; Maaser, K; Riecken, EO; Scherübl, H; Sutter, AP; Theiss, A; von Lampe, B; Zeitz, M, 2003) |
| "Barrett's esophagus is a complication of gastroesophageal reflux disease (GERD) characterized by specialized columnar epithelium that contains goblet cells and replaces the squamous epithelium of the distal esophagus." | 1.31 | [Endoscopic fluorescence diagnosis of esophageal carcinoma after sensitization with 5-aminolevulinic acid]. ( Endlicher, E; Fürst, A; Knüchel, R; Messmann, H; Schölmerich, J, 2001) |
| "Most lesions of superficial bladder cancer may be easily missed during conventional white light cystoscopy." | 1.31 | Significance of fluorescence cystoscopy for diagnosis of superficial bladder cancer after intravesical instillation of delta aminolevulinic acid. ( Ehsan, A; Engelmann, U; Haupt, G; Sommer, F, 2001) |
| "Mice grafted with HT29 colonic cancers had been given glucose and amiloride to modify the pH of tissues." | 1.31 | Enhancement of delta aminolevulinic acid-photodynamic therapy in vivo by decreasing tumor pH with glucose and amiloride. ( Bourré, L; Carré, J; Eléouet, S; Lenz, P; Patrice, T; Piot, B; Rousset, N; Vonarx, V, 2001) |
| "Eight patients with Barrett's esophagus and/or early cancer were treated." | 1.31 | [Photodynamic therapy of dysplasias and early carcinomas in Barrett esophagus with a diode laser system--a pilot study]. ( Apel, D; Arnold, JC; Jakobs, R; Riemann, JF; Rosenbaum, A; Zöpf, T, 2001) |
| " In our in vivo/in vitro model system we have shown that pre-treatment with ADM increased the cytotoxicity of ALA-PDT at a dosage level of ADM which did not raise LPO levels in heart tissue." | 1.30 | Enhancement of aminolevulinic acid based photodynamic therapy by adriamycin. ( Casas, A; del C Batlle, AM; Fukuda, H; Riley, P, 1997) |
| "PDT of Barrett's esophagus with severe dysplasia, or of mucosal carcinomas and superficial squamous-cell cancer of the esophagus, requires light application devices allowing homogeneous illumination of the tissue surface in spite of esophageal motility and respiratory movement." | 1.30 | A new long-range through-the-scope balloon applicator for photodynamic therapy in the esophagus and cardia. ( Ell, C; Gossner, L; May, A; Sroka, R, 1999) |
| "4 had squamous cell carcinoma of the mid-esophagus and 4 had adenocarcinoma of the lower esophagus." | 1.30 | [Photodynamic therapy for dysphagia due to esophageal carcinoma]. ( Haddad, R; Halpern, Z; Kashtan, H; Konikoff, F; Skornick, Y; Umansky, M, 1999) |
| "The degree of dysphagia was recorded before and 14 days after treatment." | 1.30 | [Photodynamic therapy for dysphagia due to esophageal carcinoma]. ( Haddad, R; Halpern, Z; Kashtan, H; Konikoff, F; Skornick, Y; Umansky, M, 1999) |
| "Dysphagia was improved in all except 1 patient." | 1.30 | [Photodynamic therapy for dysphagia due to esophageal carcinoma]. ( Haddad, R; Halpern, Z; Kashtan, H; Konikoff, F; Skornick, Y; Umansky, M, 1999) |
| "5-Aminolevulinic acid (5-ALA) is a precursor in the biosynthesis of haem." | 1.29 | Photodynamic therapy of experimental colonic tumours with 5-aminolevulinic-acid-induced endogenous porphyrins. ( Genze, F; König, K; Orth, K; Rück, A, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (1.04) | 18.7374 |
| 1990's | 26 (27.08) | 18.2507 |
| 2000's | 45 (46.88) | 29.6817 |
| 2010's | 22 (22.92) | 24.3611 |
| 2020's | 2 (2.08) | 2.80 |
| Authors | Studies |
|---|---|
| Matsumoto, T | 1 |
| Murayama, Y | 2 |
| Matsuo, H | 1 |
| Okochi, K | 1 |
| Koshiishi, N | 1 |
| Harada, Y | 2 |
| Tanaka, H | 2 |
| Takamatsu, T | 2 |
| Otsuji, E | 2 |
| Onishi, K | 1 |
| Miyake, M | 1 |
| Tatsumi, Y | 1 |
| Hori, S | 1 |
| Nakai, Y | 1 |
| Onishi, S | 1 |
| Iemura, Y | 1 |
| Owari, T | 1 |
| Itami, Y | 1 |
| Iida, K | 1 |
| Anai, S | 1 |
| Tanaka, N | 1 |
| Shimada, K | 1 |
| Fujimoto, K | 1 |
| Kohoutova, D | 1 |
| Haidry, R | 2 |
| Banks, M | 1 |
| Butt, MA | 1 |
| Dunn, J | 1 |
| Thorpe, S | 2 |
| Lovat, L | 1 |
| Abo-Zeid, MAM | 1 |
| Abo-Elfadl, MT | 1 |
| Mostafa, SM | 1 |
| Kurumi, H | 1 |
| Kanda, T | 1 |
| Kawaguchi, K | 1 |
| Yashima, K | 1 |
| Koda, H | 1 |
| Ogihara, K | 1 |
| Matsushima, K | 2 |
| Nakao, K | 2 |
| Saito, H | 1 |
| Fujiwara, Y | 1 |
| Osaki, M | 1 |
| Okada, F | 1 |
| Isomoto, H | 2 |
| Alkarakooly, Z | 1 |
| Al-Anbaky, QA | 1 |
| Kannan, K | 1 |
| Ali, N | 1 |
| Zakaria, S | 1 |
| Gamal-Eldeen, AM | 1 |
| El-Daly, SM | 1 |
| Saleh, S | 1 |
| Yeh, SC | 1 |
| Sahli, S | 1 |
| Andrews, DW | 1 |
| Patterson, MS | 1 |
| Armstrong, D | 1 |
| Provias, J | 1 |
| Fang, Q | 1 |
| Nanashima, A | 1 |
| Senoo, T | 1 |
| Ogiwara, K | 1 |
| Hashisako, M | 1 |
| Ohnita, K | 1 |
| Yamaguchi, N | 1 |
| Kunizaki, M | 1 |
| Hidaka, S | 1 |
| Fukuda, H | 13 |
| Ishii, H | 1 |
| Minami, H | 1 |
| Akazawa, Y | 1 |
| Takeshima, F | 1 |
| Fukuoka, J | 1 |
| Nagayasu, T | 1 |
| Rodriguez, L | 2 |
| Vallecorsa, P | 1 |
| Battah, S | 2 |
| Di Venosa, G | 6 |
| Calvo, G | 1 |
| Mamone, L | 1 |
| Sáenz, D | 1 |
| Gonzalez, MC | 1 |
| Batlle, A | 8 |
| MacRobert, AJ | 3 |
| Casas, A | 13 |
| Wiegell, SR | 1 |
| Lerche, CM | 1 |
| Wulf, HC | 1 |
| Koizumi, N | 1 |
| Beika, M | 1 |
| Minamikawa, T | 1 |
| Yamaoka, Y | 1 |
| Dai, P | 1 |
| Yanagisawa, A | 1 |
| Ascencio, M | 2 |
| Collinet, P | 2 |
| Farine, MO | 2 |
| Mordon, S | 3 |
| Dobbin, P | 1 |
| Adam, C | 1 |
| Salomon, G | 1 |
| Walther, S | 1 |
| Zaak, D | 1 |
| Khoder, W | 2 |
| Becker, A | 1 |
| Reich, O | 1 |
| Blana, A | 1 |
| Ganzer, R | 1 |
| Denzinger, S | 1 |
| Popken, G | 1 |
| Sroka, R | 3 |
| Knüchel-Clarke, R | 1 |
| Köllermann, J | 1 |
| Sauter, G | 1 |
| Hartmann, A | 1 |
| Bertz, S | 1 |
| Graefen, M | 1 |
| Huland, H | 1 |
| Wieland, W | 1 |
| Stief, CG | 1 |
| Tsai, T | 1 |
| Ji, HT | 1 |
| Chiang, PC | 1 |
| Chou, RH | 1 |
| Chang, WS | 1 |
| Chen, CT | 1 |
| Pudroma, X | 1 |
| Moan, J | 16 |
| Ma, LW | 7 |
| Iani, V | 5 |
| Juzeniene, A | 4 |
| Gross, SA | 1 |
| Wolfsen, HC | 2 |
| Wakui, M | 1 |
| Yokoyama, Y | 1 |
| Wang, H | 1 |
| Shigeto, T | 1 |
| Futagami, M | 1 |
| Mizunuma, H | 1 |
| Bhowmick, R | 2 |
| Girotti, AW | 2 |
| Park, JH | 1 |
| Moon, YH | 1 |
| Kim, DJ | 1 |
| Kim, SA | 1 |
| Lee, JB | 1 |
| Ahn, SG | 1 |
| Yoon, JH | 1 |
| Davila, ML | 1 |
| Estevez, JP | 1 |
| Colin, P | 1 |
| Ziegler, VG | 1 |
| Knaup, J | 1 |
| Stahl, D | 1 |
| Krammer, B | 1 |
| Plaetzer, K | 1 |
| Kamp, MA | 1 |
| Grosser, P | 1 |
| Felsberg, J | 1 |
| Slotty, PJ | 1 |
| Steiger, HJ | 1 |
| Reifenberger, G | 1 |
| Sabel, M | 1 |
| Kato, S | 1 |
| Kawamura, J | 1 |
| Kawada, K | 1 |
| Hasegawa, S | 1 |
| Sakai, Y | 1 |
| Guyon, L | 1 |
| Lesage, JC | 1 |
| Betrouni, N | 1 |
| Dunn, JM | 1 |
| Mackenzie, GD | 1 |
| Banks, MR | 1 |
| Mosse, CA | 1 |
| Green, S | 1 |
| Rodriguez-Justo, M | 1 |
| Winstanley, A | 1 |
| Novelli, MR | 1 |
| Bown, SG | 2 |
| Lovat, LB | 1 |
| Bermúdez Moretti, M | 2 |
| Correa García, S | 2 |
| Perotti, C | 4 |
| Prosst, RL | 2 |
| Winkler, S | 1 |
| Boehm, E | 1 |
| Gahlen, J | 2 |
| Krieg, RC | 2 |
| Messmann, H | 3 |
| Rauch, J | 1 |
| Seeger, S | 1 |
| Knuechel, R | 2 |
| Stokke, T | 3 |
| Chan, JK | 1 |
| Monk, BJ | 1 |
| Cuccia, D | 1 |
| Pham, H | 1 |
| Kimel, S | 1 |
| Gu, M | 1 |
| Hammer-Wilson, MJ | 1 |
| Liaw, LH | 1 |
| Osann, K | 1 |
| DiSaia, PJ | 1 |
| Berns, M | 1 |
| Tromberg, B | 1 |
| Tadir, Y | 2 |
| Ortner, MA | 1 |
| Ebert, B | 1 |
| Hein, E | 1 |
| Zumbusch, K | 1 |
| Nolte, D | 1 |
| Sukowski, U | 1 |
| Weber-Eibel, J | 1 |
| Fleige, B | 1 |
| Dietel, M | 1 |
| Stolte, M | 2 |
| Oberhuber, G | 1 |
| Porschen, R | 1 |
| Klump, B | 1 |
| Hörtnagl, H | 1 |
| Lochs, H | 1 |
| Rinneberg, H | 1 |
| Höpfner, M | 1 |
| Maaser, K | 1 |
| Theiss, A | 1 |
| Lenz, M | 1 |
| Sutter, AP | 1 |
| Kashtan, H | 3 |
| von Lampe, B | 1 |
| Riecken, EO | 1 |
| Zeitz, M | 1 |
| Scherübl, H | 1 |
| Uzdensky, A | 1 |
| Claydon, PE | 1 |
| Ackroyd, R | 1 |
| Juzenas, P | 1 |
| Ziolkowski, P | 1 |
| Osiecka, BJ | 1 |
| Oremek, G | 1 |
| Siewinski, M | 1 |
| Symonowicz, K | 1 |
| Saleh, Y | 1 |
| Bronowicz, A | 1 |
| Pech, O | 2 |
| Gossner, L | 4 |
| May, A | 3 |
| Rabenstein, T | 1 |
| Vieth, M | 1 |
| Berres, M | 1 |
| Ell, C | 4 |
| Macrobert, A | 1 |
| Ma, L | 4 |
| Steindal, AE | 1 |
| Alvarez, MG | 1 |
| Lacelli, MS | 1 |
| Rivarola, V | 1 |
| Sultan, SM | 1 |
| El-Doray, AA | 1 |
| Hofstetter, A | 1 |
| Abdel-Gawad, O | 1 |
| El-Mahdy, Ael-D | 1 |
| Hahn, EG | 1 |
| van Hillegersberg, R | 2 |
| Hekking-Weijma, JM | 1 |
| Wilson, JH | 2 |
| Edixhoven-Bosdijk, A | 1 |
| Kort, WJ | 1 |
| Hua, Z | 1 |
| Gibson, SL | 1 |
| Foster, TH | 1 |
| Hilf, R | 1 |
| Berg, K | 10 |
| Luksiene, Z | 1 |
| Orth, K | 1 |
| König, K | 1 |
| Genze, F | 1 |
| Rück, A | 1 |
| Cairnduff, F | 1 |
| Stringer, MR | 1 |
| Hudson, EJ | 1 |
| Ash, DV | 1 |
| Brown, SB | 2 |
| Chueke, F | 1 |
| Paredes, S | 2 |
| Batlle, AM | 6 |
| Loh, CS | 1 |
| Bedwell, J | 1 |
| Regula, J | 1 |
| Krasner, N | 1 |
| Fromm, D | 2 |
| Kessel, D | 2 |
| Webber, J | 2 |
| Noodt, BB | 1 |
| Peng, Q | 5 |
| Nesland, JM | 2 |
| Wyss-Desserich, MT | 1 |
| Sun, CH | 1 |
| Wyss, P | 1 |
| Kurlawalla, CS | 1 |
| Haller, U | 1 |
| Berns, MW | 1 |
| Anholt, H | 2 |
| Bech, O | 3 |
| Gederaas, OA | 4 |
| Thorstensen, K | 1 |
| Romslo, I | 2 |
| Heyerdahl, H | 1 |
| Wang, I | 1 |
| Liu, DL | 1 |
| Berg, R | 1 |
| Andersson-Engels, S | 1 |
| Svanberg, S | 1 |
| Svanberg, K | 1 |
| Gaullier, JM | 2 |
| Selbo, PK | 1 |
| Steen, HB | 1 |
| Riley, P | 1 |
| del C Batlle, AM | 1 |
| Konikoff, F | 2 |
| Haddad, R | 2 |
| Skornick, Y | 2 |
| Meiss, R | 1 |
| Rud, E | 1 |
| Gederaas, O | 1 |
| Høgset, A | 1 |
| Hinnen, P | 1 |
| de Rooij, FW | 1 |
| Terlouw, EM | 1 |
| Edixhoven, A | 1 |
| van Dekken, H | 1 |
| Tilanus, HW | 1 |
| Siersema, PD | 1 |
| Umansky, M | 1 |
| Halpern, Z | 1 |
| Lagerberg, JW | 1 |
| Brekke, O | 1 |
| Dubbelman, TM | 1 |
| Holroyd, A | 1 |
| Vernon, D | 1 |
| Endlicher, E | 2 |
| Knüchel, R | 1 |
| Fürst, A | 1 |
| Schölmerich, J | 2 |
| Zöpf, T | 1 |
| Rosenbaum, A | 1 |
| Apel, D | 1 |
| Jakobs, R | 1 |
| Arnold, JC | 1 |
| Riemann, JF | 1 |
| Bagdonas, S | 1 |
| Warloe, T | 1 |
| Godal, A | 1 |
| Apricena, F | 1 |
| Giercksky, KE | 1 |
| Maier, A | 3 |
| Tomaselli, F | 3 |
| Matzi, V | 3 |
| Rehak, P | 3 |
| Pinter, H | 3 |
| Smolle-Jüttner, FM | 3 |
| Brunner, H | 1 |
| Hausmann, F | 1 |
| Canis, M | 1 |
| Botchorishvili, R | 1 |
| Berreni, N | 1 |
| Manhes, H | 1 |
| Wattiez, A | 1 |
| Mage, G | 1 |
| Pouly, JL | 1 |
| Bruhat, MA | 1 |
| Ehsan, A | 1 |
| Sommer, F | 1 |
| Haupt, G | 1 |
| Engelmann, U | 1 |
| Piot, B | 1 |
| Rousset, N | 1 |
| Lenz, P | 1 |
| Eléouet, S | 1 |
| Carré, J | 1 |
| Vonarx, V | 1 |
| Bourré, L | 1 |
| Patrice, T | 1 |
| Major, AL | 1 |
| Lüdicke, F | 1 |
| Campana, A | 1 |
| Campand, A | 1 |
| Woltsche, M | 1 |
| Anegg, U | 1 |
| Fell, B | 1 |
| Nagy, CD | 1 |
4 reviews available for aminolevulinic acid and Adenocarcinoma
| Article | Year |
|---|---|
The role of photodynamic therapy in the esophagus.
Topics: Adenocarcinoma; Aminolevulinic Acid; Barrett Esophagus; Dihematoporphyrin Ether; Esophageal Neoplasm | 2010 |
Photodynamic therapy.
Topics: Adenocarcinoma; Aminolevulinic Acid; Barrett Esophagus; Dihematoporphyrin Ether; Esophageal Neoplasm | 2011 |
Photodynamic therapy for esophageal diseases: a clinical update.
Topics: Adenocarcinoma; Aminolevulinic Acid; Barrett Esophagus; Dihematoporphyrin Ether; Endosonography; Eso | 2003 |
5-Aminolaevulinic acid-induced photodynamic therapy and photodetection in Barrett's esophagus.
Topics: Adenocarcinoma; Aminolevulinic Acid; Barrett Esophagus; Clinical Trials as Topic; Esophageal Neoplas | 2004 |
10 trials available for aminolevulinic acid and Adenocarcinoma
| Article | Year |
|---|---|
Long-term outcomes of the randomized controlled trial comparing 5-aminolaevulinic acid and Photofrin photodynamic therapy for Barrett's oesophagus related neoplasia.
Topics: Adenocarcinoma; Adult; Aged; Aminolevulinic Acid; Barrett Esophagus; Catheter Ablation; Dihematoporp | 2018 |
Is the thin layer of methyl aminolevulinate used during photodynamic therapy sufficient?
Topics: Adenocarcinoma; Aged; Aminolevulinic Acid; Female; Humans; Keratosis, Actinic; Male; Photochemothera | 2016 |
Photodynamic diagnosis using 5-aminolevulinic acid for the detection of positive surgical margins during radical prostatectomy in patients with carcinoma of the prostate: a multicentre, prospective, phase 2 trial of a diagnostic procedure.
Topics: Adenocarcinoma; Aged; Aminolevulinic Acid; Biopsy, Needle; Disease-Free Survival; Humans; Immunohist | 2009 |
A randomised controlled trial of ALA vs. Photofrin photodynamic therapy for high-grade dysplasia arising in Barrett's oesophagus.
Topics: Adenocarcinoma; Aged; Aminolevulinic Acid; Barrett Esophagus; Dihematoporphyrin Ether; Disease Progr | 2013 |
Photodynamic selectivity of 5-aminolevulinic acid to prostate cancer cells.
Topics: Adenocarcinoma; Aged; Aminolevulinic Acid; Biological Availability; Combined Modality Therapy; Human | 2006 |
Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer.
Topics: Adenocarcinoma; Administration, Topical; Aminolevulinic Acid; Bowen's Disease; Breast Neoplasms; Car | 1994 |
Side effects and photosensitization of human tissues after aminolevulinic acid.
Topics: Adenocarcinoma; Administration, Oral; Aminolevulinic Acid; Female; Gastrointestinal Neoplasms; Human | 1997 |
Photodynamic therapy of cancer of the esophagus using systemic aminolevulinic acid and a non laser light source: a phase I/II study.
Topics: Adenocarcinoma; Administration, Oral; Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Squam | 1999 |
Does new photosensitizer improve photodynamic therapy in advanced esophageal carcinoma?
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Squamous Cell; Deglutition | 2001 |
Comparison of 5-aminolaevulinic acid and porphyrin photosensitization for photodynamic therapy of malignant bronchial stenosis: a clinical pilot study.
Topics: Adenocarcinoma; Aged; Aminolevulinic Acid; Bronchial Diseases; Carcinoma, Squamous Cell; Constrictio | 2002 |
82 other studies available for aminolevulinic acid and Adenocarcinoma
| Article | Year |
|---|---|
5-ALA-assistant automated detection of lymph node metastasis in gastric cancer patients.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Female; Fluorescent Dyes; Follo | 2020 |
Inhibitory Effect of Orally Administered 5-Aminolevulinic Acid on Prostate Carcinogenesis in the FVB-Transgenic Adenocarcinoma of a Mouse Prostate (FVB-TRAMP) Model.
Topics: Adenocarcinoma; Administration, Oral; Aminolevulinic Acid; Animals; Apoptosis; Carcinogenesis; Human | 2020 |
Photodynamic therapy using 5-aminolevulinic acid triggered DNA damage of adenocarcinoma breast cancer and hepatocellular carcinoma cell lines.
Topics: Adenocarcinoma; Aminolevulinic Acid; Breast Neoplasms; Carcinoma, Hepatocellular; DNA Damage; Hep G2 | 2018 |
Protoporphyrinogen oxidase is involved in the fluorescence intensity of 5-aminolevulinic acid-mediated laser-based photodynamic endoscopic diagnosis for early gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Signet Ring Cell; Co | 2018 |
Metabolic reprogramming by Dichloroacetic acid potentiates photodynamic therapy of human breast adenocarcinoma MCF-7 cells.
Topics: Adenocarcinoma; Aminolevulinic Acid; Apoptosis; Breast Neoplasms; Cell Survival; Dichloroacetic Acid | 2018 |
Synergistic apoptotic effect of Doxil ® and aminolevulinic acid-based photodynamic therapy on human breast adenocarcinoma cells.
Topics: Adenocarcinoma; Aminolevulinic Acid; Antibiotics, Antineoplastic; Apoptosis; Breast Neoplasms; Cell | 2014 |
5-Aminolevulinic acid induced protoporphyrin IX as a fluorescence marker for quantitative image analysis of high-grade dysplasia in Barrett's esophagus cellular models.
Topics: Adenocarcinoma; Algorithms; Aminolevulinic Acid; Barrett Esophagus; Biomarkers; Esophageal Neoplasms | 2015 |
In vivo fluorescence navigation of gastric and upper gastrointestinal tumors by 5-aminolevulinic acid mediated photodynamic diagnosis with a laser-equipped video image endoscope.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Signet Ring Cell; En | 2015 |
Aminolevulinic acid dendrimers in photodynamic treatment of cancer and atheromatous disease.
Topics: Adenocarcinoma; Aminolevulinic Acid; Animals; Cell Line, Tumor; Cell Survival; Dendrimers; Endocytos | 2015 |
Highly sensitive fluorescence detection of metastatic lymph nodes of gastric cancer with photo-oxidation of protoporphyrin IX.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Cell Line, Tumor; Female; Human | 2016 |
Protoporphyrin IX fluorescence photobleaching is a useful tool to predict the response of rat ovarian cancer following hexaminolevulinate photodynamic therapy.
Topics: Adenocarcinoma; Aminolevulinic Acid; Animals; Female; Microscopy, Fluorescence; Ovarian Neoplasms; P | 2008 |
Sustained and efficient porphyrin generation in vivo using dendrimer conjugates of 5-ALA for photodynamic therapy.
Topics: Adenocarcinoma; Aminolevulinic Acid; Animals; Cell Line, Tumor; Cell Survival; Coloring Agents; Dend | 2009 |
ALA-PDT results in phenotypic changes and decreased cellular invasion in surviving cancer cells.
Topics: Adenocarcinoma; Aminolevulinic Acid; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Down-Regulat | 2009 |
A comparison of 5-aminolaevulinic acid- and its heptyl ester: dark cytotoxicity and protoporphyrin IX synthesis in human adenocarcinoma WiDr cells and in athymic nude mice healthy skin.
Topics: Adenocarcinoma; Aminolevulinic Acid; Animals; Cell Line, Tumor; Drug Screening Assays, Antitumor; Hu | 2009 |
Efficacy of a methyl ester of 5-aminolevulinic acid in photodynamic therapy for ovarian cancers.
Topics: Adenocarcinoma; Aminolevulinic Acid; Animals; Apoptosis; Cell Division; Cell Line, Tumor; Disease Mo | 2010 |
Cytoprotective induction of nitric oxide synthase in a cellular model of 5-aminolevulinic acid-based photodynamic therapy.
Topics: Adenocarcinoma; Aminolevulinic Acid; Apoptosis; Breast Neoplasms; Caspases; Cell Line, Tumor; Cytopr | 2010 |
Photodynamic therapy with hexenyl ester of 5-aminolevulinic acid induces necrotic cell death in salivary gland adenocarcinoma cells.
Topics: Adenocarcinoma; Aminolevulinic Acid; Animals; Antineoplastic Agents; Cell Death; Cell Line, Tumor; C | 2010 |
Continuous or fractionated photodynamic therapy? Comparison of three PDT schemes for ovarian peritoneal micrometastasis treatment in a rat model.
Topics: Adenocarcinoma; Aminolevulinic Acid; Animals; Disease Models, Animal; Female; Ovarian Neoplasms; Per | 2010 |
Fluorescence detection and depletion of T47D breast cancer cells from human mononuclear cell-enriched blood preparations by photodynamic treatment: Basic in vitro experiments towards the removal of circulating tumor cells.
Topics: Adenocarcinoma; Aminolevulinic Acid; Animals; Breast Neoplasms; Cell Line; Cell Line, Tumor; Endothe | 2011 |
5-aminolevulinic acid (5-ALA)-induced fluorescence in intracerebral metastases: a retrospective study.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Aminolevulinic Acid; Brain Neoplasms; Carcinoma; Female; Fl | 2012 |
Fluorescence diagnosis of metastatic lymph nodes using 5-aminolevulinic acid (5-ALA) in a mouse model of colon cancer.
Topics: Adenocarcinoma; Aminolevulinic Acid; Animals; Cell Line, Tumor; Colonic Neoplasms; Female; Fluoresce | 2012 |
Development of a new illumination procedure for photodynamic therapy of the abdominal cavity.
Topics: Abdominal Cavity; Adenocarcinoma; Aminolevulinic Acid; Animals; Cell Line, Tumor; Female; Intestines | 2012 |
Cytoprotective signaling associated with nitric oxide upregulation in tumor cells subjected to photodynamic therapy-like oxidative stress.
Topics: Adenocarcinoma; Aminolevulinic Acid; Apoptosis; Apoptosis Regulatory Proteins; Breast Neoplasms; Cel | 2013 |
Delta-Aminolevulinic acid transport in murine mammary adenocarcinoma cells is mediated by beta transporters.
Topics: Adenocarcinoma; Aminolevulinic Acid; Animals; Biological Transport, Active; Mammary Neoplasms, Exper | 2002 |
Thoracoscopic fluorescence diagnosis (TFD) of pleural malignancies: experimental studies.
Topics: Adenocarcinoma; Aminolevulinic Acid; Animals; Female; Fluorescence; Humans; Lung Neoplasms; Mice; Mi | 2002 |
Metabolic characterization of tumor cell-specific protoporphyrin IX accumulation after exposure to 5-aminolevulinic acid in human colonic cells.
Topics: Adenocarcinoma; Aminolevulinic Acid; Cell Line, Tumor; Colonic Neoplasms; Dose-Response Relationship | 2002 |
Transfer of protoporphyrin IX between cells.
Topics: Adenocarcinoma; Aminolevulinic Acid; Cell Communication; Cell Line, Tumor; Colonic Neoplasms; Humans | 2002 |
Laparoscopic photodynamic diagnosis of ovarian cancer using 5-aminolevulinic acid in a rat model.
Topics: Adenocarcinoma; Aminolevulinic Acid; Animals; Female; Fluorescence; Laparoscopy; Neoplasm Metastasis | 2002 |
Time gated fluorescence spectroscopy in Barrett's oesophagus.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Barrett Esophagus; Biomarkers, | 2003 |
Hypericin activated by an incoherent light source has photodynamic effects on esophageal cancer cells.
Topics: Adenocarcinoma; Aminolevulinic Acid; Anthracenes; Antineoplastic Agents; Apoptosis; Carcinoma, Squam | 2003 |
Mechanistic studies on delta-aminolevulinic acid uptake and efflux in a mammary adenocarcinoma cell line.
Topics: Adenocarcinoma; Aminolevulinic Acid; Animals; gamma-Aminobutyric Acid; Mammary Neoplasms, Animal; Mi | 2003 |
Photodynamic inhibition of enzymatic detachment of human cancer cells from a substratum.
Topics: Adenocarcinoma; Aminolevulinic Acid; Cell Adhesion; Cell Line, Tumor; Cell Membrane; Cell Survival; | 2004 |
Effectiveness of different light sources for 5-aminolevulinic acid photodynamic therapy.
Topics: Adenocarcinoma; Aminolevulinic Acid; Animals; Colonic Neoplasms; Female; Humans; In Vitro Techniques | 2004 |
Enhancement of photodynamic therapy by use of aminolevulinic acid/glycolic acid drug mixture.
Topics: Adenocarcinoma; Administration, Cutaneous; Aged; Aminolevulinic Acid; Animals; Antineoplastic Combin | 2004 |
Sensitivity to ALA-PDT of cell lines with different nitric oxide production and resistance to NO cytotoxicity.
Topics: Adenocarcinoma; Aminolevulinic Acid; Animals; Cell Line; Cell Line, Tumor; Cell Survival; Female; L | 2005 |
Long-term results of photodynamic therapy with 5-aminolevulinic acid for superficial Barrett's cancer and high-grade intraepithelial neoplasia.
Topics: Adenocarcinoma; Aged; Aminolevulinic Acid; Barrett Esophagus; Disease-Free Survival; Esophageal Neop | 2005 |
No cross-resistance between ALA-mediated photodynamic therapy and nitric oxide.
Topics: Adenocarcinoma; Aminolevulinic Acid; Animals; Cell Line, Tumor; Cell Survival; Drug Resistance, Neop | 2005 |
Photodynamic therapy: regulation of porphyrin synthesis and hydrolysis from ALA esters.
Topics: Adenocarcinoma; Aminolevulinic Acid; Animals; Biological Transport, Active; Cell Line, Tumor; Female | 2006 |
The effect of folic acid on porphyrin synthesis in tumors and normal skin of mice treated with 5-aminolevulinic acid or methyl 5-aminolevulinate.
Topics: Adenocarcinoma; Aminolevulinic Acid; Animals; Colonic Neoplasms; Female; Folic Acid; Humans; Injecti | 2006 |
5-aminolevulinic acid-mediated photodynamic therapy on Hep-2 and MCF-7c3 cells.
Topics: Adenocarcinoma; Aminolevulinic Acid; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Survival; D | 2007 |
Photodynamic therapy: successful destruction of gastrointestinal cancer after oral administration of aminolevulinic acid.
Topics: Adenocarcinoma; Administration, Oral; Aged; Aged, 80 and over; Aminolevulinic Acid; Esophageal Neopl | 1995 |
Adjuvant intraoperative photodynamic therapy diminishes the rate of local recurrence in a rat mammary tumour model.
Topics: Adenocarcinoma; Aminolevulinic Acid; Analysis of Variance; Animals; Chemotherapy, Adjuvant; Female; | 1995 |
Effectiveness of delta-aminolevulinic acid-induced protoporphyrin as a photosensitizer for photodynamic therapy in vivo.
Topics: Adenocarcinoma; Aminolevulinic Acid; Animals; Cell Division; Chromatography, High Pressure Liquid; F | 1995 |
Combined treatment of ionizing radiation and photosensitization by 5-aminolevulinic acid-induced protoporphyrin IX.
Topics: Adenocarcinoma; Aminolevulinic Acid; Cell Cycle; Cell Division; Cell Line; Cell Survival; Colonic Ne | 1995 |
Photodynamic therapy of experimental colonic tumours with 5-aminolevulinic-acid-induced endogenous porphyrins.
Topics: Adenocarcinoma; Administration, Oral; Aminolevulinic Acid; Animals; Cell Division; Colonic Neoplasms | 1994 |
Photodynamic action of endogenously synthesized porphyrins from aminolevulinic acid, using a new model for assaying the effectiveness of tumoral cell killing.
Topics: Adenocarcinoma; Aminolevulinic Acid; Animals; Biological Assay; Cell Death; Cell Division; Combined | 1993 |
Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy.
Topics: Adenocarcinoma; Administration, Oral; Aminolevulinic Acid; Animals; Colon; Colonic Neoplasms; Gastri | 1993 |
Feasibility of photodynamic therapy using endogenous photosensitization for colon cancer.
Topics: Adenocarcinoma; Administration, Oral; Aminolevulinic Acid; Biopsy; Colectomy; Colon, Sigmoid; Follow | 1996 |
Apoptosis and necrosis induced with light and 5-aminolaevulinic acid-derived protoporphyrin IX.
Topics: Adenocarcinoma; Aminolevulinic Acid; Animals; Apoptosis; Cells, Cultured; Colonic Neoplasms; Criceti | 1996 |
Accumulation of 5-aminolevulinic acid-induced protoporphyrin IX in normal and neoplastic human endometrial epithelial cells.
Topics: Adenocarcinoma; Aminolevulinic Acid; Cells, Cultured; Endometrial Neoplasms; Endometrium; Epithelial | 1996 |
The influence of iron chelators on the accumulation of protoporphyrin IX in 5-aminolaevulinic acid-treated cells.
Topics: Adenocarcinoma; Aminolevulinic Acid; Animals; Colonic Neoplasms; Cricetinae; Cricetulus; Dicarbethox | 1996 |
The effect of brief illumination on intracellular free calcium concentration in cells with 5-aminolevulinic acid-induced protoporphyrin IX synthesis.
Topics: Adenocarcinoma; Aminolevulinic Acid; Calcium; Colonic Neoplasms; Cytosol; DNA; Egtazic Acid; Fluores | 1996 |
The pH dependency of protoporphyrin IX formation in cells incubated with 5-aminolevulinic acid.
Topics: Adenocarcinoma; Aminolevulinic Acid; Animals; Cell Survival; Colonic Neoplasms; Cricetinae; Fibrobla | 1997 |
Pharmacokinetic studies on 5-aminolevulinic acid-induced protoporphyrin IX accumulation in tumours and normal tissues.
Topics: Adenocarcinoma; Aminolevulinic Acid; Animals; Carcinoma, Basal Cell; Drug Interactions; Humans; Live | 1997 |
Use of 5-aminolevulinic acid esters to improve photodynamic therapy on cells in culture.
Topics: Adenocarcinoma; Aminolevulinic Acid; Animals; Colonic Neoplasms; Cricetinae; Cricetulus; Drug Screen | 1997 |
Protoporphyrin IX accumulation in cells treated with 5-aminolevulinic acid: dependence on cell density, cell size and cell cycle.
Topics: Adenocarcinoma; Aminolevulinic Acid; Animals; Cell Communication; Cell Count; Cell Cycle; Cell Line; | 1998 |
Enhancement of aminolevulinic acid based photodynamic therapy by adriamycin.
Topics: Adenocarcinoma; Aminolevulinic Acid; Ammonia-Lyases; Animals; Doxorubicin; Drug Therapy, Combination | 1997 |
Production of protoporphyrin IX induced by 5-aminolevulinic acid in transplanted human colon adenocarcinoma of nude mice can be increased by ultrasound.
Topics: Adenocarcinoma; Aminolevulinic Acid; Animals; Colonic Neoplasms; Female; Humans; Mice; Mice, Inbred | 1998 |
Potentiation of the 5-aminolevulinic acid-based photodynamic therapy with cyclophosphamide.
Topics: Adenocarcinoma; Aminolevulinic Acid; Animals; Antineoplastic Agents, Alkylating; Combined Modality T | 1998 |
A new long-range through-the-scope balloon applicator for photodynamic therapy in the esophagus and cardia.
Topics: Adenocarcinoma; Aged; Aminolevulinic Acid; Barrett Esophagus; Biopsy; Carcinoma, Squamous Cell; Card | 1999 |
Topical and intratumoral photodynamic therapy with 5-aminolevulinic acid in a subcutaneous murine mammary adenocarcinoma.
Topics: Adenocarcinoma; Administration, Topical; Aminolevulinic Acid; Animals; Cell Division; Injections, In | 1999 |
Tissue distribution and kinetics of endogenous porphyrins synthesized after topical application of ALA in different vehicles.
Topics: Adenocarcinoma; Administration, Topical; Aminolevulinic Acid; Animals; Kinetics; Male; Mammary Neopl | 1999 |
A comparative study of normal and reverse phase high pressure liquid chromatography for analysis of porphyrins accumulated after 5-aminolaevulinic acid treatment of colon adenocarcinoma cells.
Topics: Adenocarcinoma; Aminolevulinic Acid; Chromatography, High Pressure Liquid; Colonic Neoplasms; Humans | 2000 |
5-aminolevulinic acid, but not 5-aminolevulinic acid esters, is transported into adenocarcinoma cells by system BETA transporters.
Topics: Adenocarcinoma; Amino Acid Transport Systems; Aminolevulinic Acid; Biological Transport; Carrier Pro | 2000 |
Porphyrin biosynthesis in human Barrett's oesophagus and adenocarcinoma after ingestion of 5-aminolaevulinic acid.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Barrett E | 2000 |
[Photodynamic therapy for dysphagia due to esophageal carcinoma].
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Squamous Cell; Deglutition | 1999 |
The influence of the vehicle on the synthesis of porphyrins after topical application of 5-aminolaevulinic acid. Implications in cutaneous photodynamic sensitization.
Topics: Adenocarcinoma; Administration, Topical; Aminolevulinic Acid; Animals; Carbon Radioisotopes; Dimethy | 2000 |
5-aminolevulinic acid induced lipid peroxidation after light exposure on human colon carcinoma cells and effects of alpha-tocopherol treatment.
Topics: Adenocarcinoma; Aminolevulinic Acid; Cell Survival; Colonic Neoplasms; Dose-Response Relationship, R | 2000 |
5-Aminolaevulinic acid methyl ester transport on amino acid carriers in a human colon adenocarcinoma cell line.
Topics: Adenocarcinoma; Amino Acid Transport Systems; Amino Acids; Aminolevulinic Acid; Antimetabolites; Bio | 2001 |
On the pharmacokinetics of topically applied 5-aminolevulinic acid and two of its esters.
Topics: Adenocarcinoma; Administration, Cutaneous; Aminolevulinic Acid; Animals; Colonic Neoplasms; Female; | 2001 |
[Endoscopic fluorescence diagnosis of esophageal carcinoma after sensitization with 5-aminolevulinic acid].
Topics: Adenocarcinoma; Aminolevulinic Acid; Barrett Esophagus; Diagnosis, Differential; Esophageal Neoplasm | 2001 |
[Photodynamic therapy of dysplasias and early carcinomas in Barrett esophagus with a diode laser system--a pilot study].
Topics: Adenocarcinoma; Aged; Aminolevulinic Acid; Barrett Esophagus; Cell Transformation, Neoplastic; Esoph | 2001 |
The photosensitizing effect of the photoproduct of protoporphyrin IX.
Topics: Adenocarcinoma; Aminolevulinic Acid; Cell Membrane; Humans; Methylene Blue; Photochemotherapy; Propi | 2001 |
Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.
Topics: Adenocarcinoma; Aminolevulinic Acid; Animals; Cell Survival; Colonic Neoplasms; Dihematoporphyrin Et | 2001 |
Photosensitization with hematoporphyrin derivative compared to 5-aminolaevulinic acid for photodynamic therapy of esophageal carcinoma.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Squamous Cell; Esophageal N | 2001 |
The effects of 5-aminolevulinic acid esters on protoporphyrin IX production in human adenocarcinoma cell lines.
Topics: Adenocarcinoma; Aminolevulinic Acid; Dose-Response Relationship, Drug; Esters; Fibroblasts; Flow Cyt | 2001 |
5-aminolevulinic acid-induced (ALA) fluorescence for the laparoscopic diagnosis of peritoneal metastasis. AST An experimental study.
Topics: Adenocarcinoma; Aminolevulinic Acid; Animals; Female; Fluorescence; Laparoscopy; Ovarian Neoplasms; | 2001 |
Significance of fluorescence cystoscopy for diagnosis of superficial bladder cancer after intravesical instillation of delta aminolevulinic acid.
Topics: Adenocarcinoma; Administration, Intravesical; Aged; Aged, 80 and over; Aminolevulinic Acid; Biopsy; | 2001 |
Enhancement of delta aminolevulinic acid-photodynamic therapy in vivo by decreasing tumor pH with glucose and amiloride.
Topics: Acid-Base Equilibrium; Adenocarcinoma; Amiloride; Aminolevulinic Acid; Animals; Colonic Neoplasms; H | 2001 |
Feasibility study to detect ovarian cancer micrometastases by fluorescence photodetection.
Topics: Adenocarcinoma; Aminolevulinic Acid; Fear; Female; Fluorescence; Humans; Laparoscopy; Middle Aged; O | 2002 |
Photodynamic therapy of human Barrett's cancer using 5-aminolaevulinic acid-induced protoporphyrin IX: an in-vivo dosimetry study in athymic nude mice.
Topics: Adenocarcinoma; Aminolevulinic Acid; Animals; Barrett Esophagus; Esophageal Neoplasms; Humans; Mice; | 2002 |
Tumor-localizing properties of porphyrins. In vitro studies using the porphyrin precursor, aminolevulinic acid, in free and liposome encapsulated forms.
Topics: Adenocarcinoma; Aminolevulinic Acid; Animals; Liposomes; Male; Mammary Neoplasms, Experimental; Mice | 1989 |